na.ramos
Submits third-party assay reports on material purchased directly. Based in Mysuru.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.36%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042952 | Semax | MKM | MKM-2512-B3991 | Medutest | 2026-Q2 | 98.93 | 7.12 | — | Buyer-sourced | 2 | FAIL |
| AX-2026-042787 | Retatrutide | GGPeps | GGPE-2510-R1919 | Janoshik | 2026-Q1 | 99.12 | 3.30 | 92.9 | Supplier-supplied | 0 | PASS |
| AX-2025-018976 | Oxytocin | ASY | ASY-{CAT}-1898 | VendorInvestigate | 2025-Q4 | 99.63 | 3.96 | 98.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020546 | PEG-MGF | SSA | SSA-2505-U7007 | Janoshik | 2025-Q4 | 96.05 | 2.65 | 106.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020742 | Triptorelin | SGN | SGN-2504-A9334 | Medutest | 2025-Q2 | 98.54 | 4.24 | 90.1 | Buyer-sourced | 1 | FAIL |
| AX-2025-020401 | Tirzepatide | MKM | MKM-2411-B3993 | Medutest | 2025-Q2 | 98.13 | 4.02 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021172 | SS-31 (Elamipretide) | PPG | PPG-2411-D6795 | Janoshik | 2025-Q1 | 99.93 | 5.42 | — | Buyer-sourced | 0 | PASS |
| AX-2024-004798 | BPC-157 | HJ | HJ-2402-M6198 | PeptideMeter | 2024-Q2 | 99.86 | 4.53 | 105.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004256 | Sermorelin | QYB | QYB-2404-W4423 | Janoshik | 2024-Q2 | 99.59 | 3.36 | 104.3 | Buyer-sourced | 0 | PASS |
| AX-2024-004201 | IGF-1 LR3 | WWB | WWB-2310-A4053 | PeptideMeter | 2024-Q1 | 99.59 | 5.18 | 98.0 | Buyer-sourced | 0 | PASS |